Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309
Clinical trial NCT05957081 · RECRUITING
Trial details
- NCT number
- NCT05957081
- Sponsor
- PharmAbcine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2029-10-30
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.